22 八月 2014

歡迎來到Nixon-TAM (Twin and Multiplex) 香港炎症性腸病資料庫網站

二十年來,炎症性腸病在亞洲的發病率不斷上升,中大消化疾病研究所於亞太區九個國家及地區,進行炎症性腸病的流行病學研究,結果發現,香港和澳門的炎症性腸病新增個案更高踞首三位,本港炎症性腸病的整體發病率為每十萬人有3人,與1991年至2001年時本港每十萬人只有一人患上炎症性腸病的發病率比較,增加了三倍。

由於本港缺乏有系統的炎症性腸病數據,醫生和患者可能因意識不足而忽視表徵及延誤診斷,導致不能有效地控制病情。

有見及此,Nixon-TAM 香港炎症性腸病資料庫的成立,希望能夠以統計本港炎症性腸病患者的人數,病徵,治療方法,以及疾病預測。除此之外,希望藉此提升市民對炎症性腸病的認知,從而減低延誤診斷的情況,讓病人及早就醫。本港十三間公立醫院將參與此資料統計。

如果您已被確診或疑似炎症性腸病患者,而有興趣參與這項研究,可致電2632-1519登記或按此填寫資料

如果您是醫護人員,希望轉介病人參與這項研究,可致電2632-1519與我們聯絡

22 八月 2014

In the past two decades, the incidence of Inflammatory Bowel Disease (IBD) has been increasing in Asia. Our recent epidemiology study across nine countries in Asia-Pacific showed that Hong Kong and Macau are among the top three regions with the highest incidence of IBD. The incidence of Hong Kong was 3.0 per 100,000. There has been a three-fold increase in the incidence of IBD patients in Hong Kong from 1.0 in 1991-2001 to 3.0 per 100,000 in 2013. Complicated and penetrating Crohn’s disease is common in Asia.

Due to the lack of systematic data collection of IBD in Hong Kong, its diagnosis may be delayed because of poor awareness among physicians and patients.

The Nixon-TAM (Twin and Multiplex) Hong Kong IBD Registry aims to investigate the prevalence, disease characteristics, treatment, and prognosis of IBD patients in Hong Kong. 13 public hospitals will participate in the registry.

If you are an IBD or suspected IBD patient, and would like join the registry please call 26321519 or click here

If you are a clinician who would like to refer patients who may be interested in joining the registry please contact us at 26321519

22 八月 2014

歡迎光臨

22 八月 2014

HK IBD consensus
IBD Registry Investigators Login
Incidence and phenotype of inflammatory bowel disease based on results from the Asia-pacific Crohn’s and colitis epidemiology study
See Further information here.